Literature DB >> 21074104

An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe.

Matteo Malvezzi1, Martina Bonifazi, Paola Bertuccio, Fabio Levi, Carlo La Vecchia, Adriano Decarli, Eva Negri.   

Abstract

PURPOSE: To analyze the components of the favorable trends in gastric cancer in Europe.
METHODS: From official certified deaths from gastric cancer and population estimates for 42 countries of the European geographical region, during the period 1950 to 2007, age-standardized death rates (World Standard Population) were computed, and an age-period-cohort analysis was performed.
RESULTS: Central and Northern countries with lower rates in the 2005 to 2007 period, such as France (5.28 and 1.93/100,000, men and women respectively) and Sweden (4.49 and 2.21/100,000), had descending period and cohort effects that decreased steeply from the earliest cohorts until those born in the 1940s, to then stabilize. Former nonmarket economy countries had mortality rates greater than 20/100,000 men and 10/100,000 women, and displayed a later start in the cohort effect fall, which continued in the younger cohorts. Mortality remained high in some countries of Southern and Eastern Europe.
CONCLUSIONS: The decrease in gastric cancer mortality was observed in both cohort and period effects but was larger in the cohorts, suggesting that the downward trends are likely to persist in countries with higher rates. In a few Western countries with very low rates an asymptote appears to have been reached for cohorts born after the 1940s, particularly in women.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21074104     DOI: 10.1016/j.annepidem.2010.08.013

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  15 in total

1.  MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.

Authors:  Yongfeng Cao; Jiaye Song; Jianjuan Ge; Zhuchen Song; Jia Chen; Changping Wu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

2.  [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].

Authors:  Wanxia Yang; Yunyan Pan; Peiwen Guan; Xue Li; Chongge You
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

3.  Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States.

Authors:  Michitaka Honda; Sandra L Wong; Mark A Healy; Toshifusa Nakajima; Masayuki Watanabe; Shingo Fukuma; Shunichi Fukuhara; John Z Ayanian
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

4.  Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.

Authors:  Jia-Hong Wang; Hong-Sheng Tang; Xiao-Shan Li; Xiang-Liang Zhang; Xian-Zi Yang; Li-Si Zeng; Qiang Ruan; Yong-Hong Huang; Gao-Jie Liu; Jin Wang; Shu-Zhong Cui
Journal:  Oncotarget       Date:  2017-05-09

5.  Bayesian adjustment of gastric cancer mortality rate in the presence of misclassification.

Authors:  Nastaran Hajizadeh; Mohamad Amin Pourhoseingholi; Ahmad Reza Baghestani; Alireza Abadi; Mohammad Reza Zali
Journal:  World J Gastrointest Oncol       Date:  2017-04-15

6.  Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes.

Authors:  Yushuai Mi; Senlin Zhao; Chongzhi Zhou; Junyong Weng; Jikun Li; Zhanshan Wang; Huimin Sun; Huamei Tang; Xin Zhang; Xiaofeng Sun; Zhihai Peng; Yugang Wen
Journal:  Oncotarget       Date:  2016-09-13

7.  Cohort Analysis of Epithelial Cancer Mortality Male-to-Female Sex Ratios in the European Union, USA, and Japan.

Authors:  Greta Carioli; Paola Bertuccio; Fabio Levi; Paolo Boffetta; Eva Negri; Carlo La Vecchia; Matteo Malvezzi
Journal:  Int J Environ Res Public Health       Date:  2020-07-23       Impact factor: 3.390

8.  Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.

Authors:  Gengming Niu; Yazhe Yang; Jun Ren; Tao Song; Zhiqing Hu; Liang Chen; Runqi Hong; Jie Xia; Chongwei Ke; Xin Wang
Journal:  Oncol Rep       Date:  2019-07-30       Impact factor: 3.906

Review 9.  Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis.

Authors:  Hua Ge; Xueyan He; Lingfei Guo; Xianzhi Yang
Journal:  Onco Targets Ther       Date:  2017-09-13       Impact factor: 4.147

10.  Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.

Authors:  Ying Liu; Liuxi Chen; Ruonan Zhang; Bi Chen; Yu Xiang; Mingming Zhang; Xingxing Huang; Wenzheng Zhang; Xiaying Chen; Ting Pan; Lili Yan; Ting Jin; Shuiping Liu; Jiao Feng; Ting Duan; Tian Xie; Shuang Lin; Xinbing Sui
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.